Avoro Capital Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $25.9M | Sell |
|
|||||
|
2024
Q3 | $39.8M | Sell |
|
|||||
|
2024
Q2 | $93.8M | Hold |
|
|||||
|
2024
Q1 | $173M | Buy |
|
|||||
|
2023
Q4 | $54.5M | Hold |
|
|||||
|
2023
Q3 | $30.5M | Hold |
|
|||||
|
2023
Q2 | $47.2M | Sell |
|
|||||
|
2023
Q1 | $42.9M | Hold |
|
|||||
|
2022
Q4 | $44.9M | Sell |
|
|||||
|
2022
Q3 | $86.4M | Sell |
|
|||||
|
2022
Q2 | $102M | Buy |
|
|||||
|
2022
Q1 | $152M | Buy |
|
|||||
|
2021
Q4 | $166M | Buy |
|
|||||
|
2021
Q3 | $210M | Sell |
|
|||||
|
2021
Q2 | $237M | Buy |
|
|||||
|
2021
Q1 | $253M | Buy |
|
|||||
|
2020
Q4 | $348M | Sell |
|
|||||
|
2020
Q3 | $314M | Sell |
|
|||||
|
2020
Q2 | $284M | Buy |
|
|||||
|
2020
Q1 | $270M | Buy |
|
|||||
|
2019
Q4 | $244M | Sell |
|
|||||
|
2019
Q3 | $193M | Sell |
|
|||||
|
2019
Q2 | $264M | Buy |
|
|||||
|
2019
Q1 | $100M | Buy |
|
|||||
|
2018
Q4 | $90.8M | Buy |
|
|||||
|
2018
Q3 | $97.5M | Buy |
|
|||||
|
2018
Q2 | $105M | Buy |
|
|||||
|
2018
Q1 | $137M | Buy |
|
|||||
|
2017
Q4 | $42M | Buy |
|
|||||
|
2017
Q3 | $32.6M | Buy |
|
|||||
|
2017
Q2 | $30.5M | Sell |
|
|||||
|
2017
Q1 | $33.9M | Buy |
|
|||||
|
2016
Q4 | $31.4M | Buy |
|
|||||
|
2016
Q3 | $35M | Sell |
|
|||||
|
2016
Q2 | $35.1M | Buy |
|
|||||
|
2016
Q1 | $15.9M | Sell |
|
|||||
|
2015
Q4 | $24.6M | Buy |
|
|||||
|
2015
Q3 | $18.3M | Buy |
|
|||||
|
2015
Q2 | $26.8M | Buy |
|
|||||
|
2015
Q1 | $26M | Buy |
|